Dr. Molldrem’s talk focused on the history of controversies over molecular HIV surveillance and cluster detection and response programs in the United States, along with the potential role of consent in these public health activities. The presentation included a discussion of recent developments, particularly changes to program guidelines from the Centers for Disease Control and Prevention (CDC).